Business / Finance

RSS

Rexahn Pharmaceuticals signs license agreement with UMB for novel drug delivery platform

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, announced today that it has signed an exclusive license agreement with the University of Maryland, Baltimore for a novel drug delivery platform, Nano-Polymer-Drug Conjugate Systems.

17 Jul 2013

ComQi, Aceso partner to serve healthcare sector with turn-key digital media solutions

ComQi, the global multi-channel message management company, and Aceso, a healthcare management and communications solutions provider, announced their partnership in serving the healthcare sector with turn-key digital media solutions.

17 Jul 2013

Mindray acquires ZONARE Medical Systems

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it has completed the acquisition of ZONARE Medical Systems, Inc., an ultrasound technology leader in the high-end radiology segment pursuant to the terms of the previously announced definitive agreement entered into on June 12, 2013.

From Mindray 17 Jul 2013

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Spectrum Pharmaceuticals, Inc., a biotechnology company with fully-integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that, through a wholly-owned subsidiary, the company entered into an agreement to acquire Talon Therapeutics, Inc., a biopharmaceutical company based in South San Francisco, California, and expects to complete the acquisition within one day.

17 Jul 2013

Sequella licenses Pfizer's exclusive worldwide rights to develop, commercialize sutezolid

Sequella, a clinical-stage pharmaceutical company commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it has licensed Pfizer Inc's exclusive worldwide rights to develop and commercialize sutezolid, a Phase 2 oxazolidinone antibiotic currently in development for the treatment of tuberculosis.

17 Jul 2013

Catholic Health Initiatives creates new MSO to deliver physician-management services

Catholic Health Initiatives has formed a new management-services organization to deliver key business functions and physician-management services under a centralized, national organization across eight divisions.

17 Jul 2013

OneHealth Solutions signs strategic alliance with New Directions Behavioral Health

OneHealth Solutions, Inc., the leading behavior change platform company improving health outcomes and the cost of care for patients, providers, payers and employers, has entered into a strategic alliance with New Directions Behavioral Health, one of the fastest growing behavioral health care companies in the nation, to expand services into eHealth, mHealth and social networking for its members.

16 Jul 2013

LodgeNet Healthcare becomes SONIFI HEALTH Solutions

LodgeNet Healthcare, the leading provider of integrated patient engagement solutions, announced today that post-acquisition, it has been rebranded as SONIFI HEALTH Solutions.

16 Jul 2013

Zecotek partners with Hamamatsu to commercialize existing imaging technologies

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its wholly owned subsidiary Zecotek Imaging Systems Pte. Ltd. has signed a joint collaboration partnership agreement with Hamamatsu Photonics (Tokyo: 6965) of Japan to commercialize existing imaging technologies and to collaborate on the upgrade and manufacture of photo detectors, integrated detector modules (IDM) and associated electronics and data acquisition modules for the imaging markets at large.

16 Jul 2013

ADC Therapeutics, BZL Biologics sign licensing deal for antibody against PSMA-positive prostate cancers

ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and BZL Biologics LLC, of New York, today announced an exclusive licensing and collaboration agreement for an antibody against PSMA-positive prostate cancers.

15 Jul 2013

Ipsen closes acquisition of UK-based Syntaxin

Ipsen announced today the closing of the acquisition of Syntaxin, a UK-based private life sciences company specialized in botulinum toxin engineering.

15 Jul 2013

PathoQuest closes new fundraising of EUR 3.8 million

PathoQuest, a new generation molecular diagnostics company that offers a new approach based on NGS (Next Generation Sequencing) in the field of infectious diseases, announces today the closing of a new fundraising of EUR 3.8 million.

12 Jul 2013

Boehringer Ingelheim signs multi-year renewal agreement to NextBio Research Platform

NextBio, whose Big Data technology enables users to apply genomic data from disparate sources in novel and useful ways across life sciences research, today announced that Boehringer Ingelheim has signed a multi-year renewal agreement to the NextBio Research Platform.

9 Jul 2013

Acorda Therapeutics acquires two neuropathic pain management assets from NeurogesX

Acorda Therapeutics, Inc. today announced that it has acquired two neuropathic pain management assets from NeurogesX, Inc. Qutenza is approved by the U.S. Food and Drug Administration for the management of neuropathic pain associated with postherpetic neuralgia.

9 Jul 2013

Glythera secures £700k to advance development of new generation of biological therapeutics

Glythera Ltd is delighted to announce that it has successfully achieved a number of technical and commercial milestones which has resulted in the release of a second tranche of funding totalling £700k from IP Group and its managed fund, the Finance for Business North East Technology Fund.

9 Jul 2013

Leica Biosystems announces acquisition of Kreatech Diagnostics

Leica Biosystems announced that it has acquired Kreatech Diagnostics, a privately-held provider of DNA fluorescent in-situ hybridization probes and target labeling reagents for microarrays.

9 Jul 2013

BioNano Genomics signs strategic partnership with New York Genome Center

BioNano Genomics and the New York Genome Center announced today a strategic partnership between the two institutions that includes the purchase of an Irys System by NYGC.

8 Jul 2013

Life Care Medical Devices inks exclusive distribution agreement with M.E.D. Surgical

Life Care Medical Devices Ltd., a development stage medical device company today announced that Life Care Medical Devices, Ltd, Ireland signed an exclusive agreement with M.E.D. Surgical, a subsidiary of Sisk Healthcare for the distribution of the Company's Keyhole Cup Laparoscopic Access Device in the Republic of Ireland territories and Northern Ireland.

8 Jul 2013

Soligenix announces personalized medicine collaboration with SciClone

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced a personalized medicine collaboration with SciClone Pharmaceuticals in the Company's oral mucositis clinical program with SGX942.

8 Jul 2013

Capricor to become wholly-owned subsidiary of Nile Therapeutics

Capricor, Inc., a privately held biotechnology company developing cardiac stem cell therapeutics to repair damaged heart muscle, and Nile Therapeutics, Inc. announced today that they have entered into a Merger Agreement under which Capricor will become a wholly-owned subsidiary of Nile Therapeutics, Inc. in an all-stock transaction.

8 Jul 2013

Business / Finance

Rexahn Pharmaceuticals signs license agreement with UMB for novel drug delivery platform

ComQi, Aceso partner to serve healthcare sector with turn-key digital media solutions

Mindray acquires ZONARE Medical Systems

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Sequella licenses Pfizer's exclusive worldwide rights to develop, commercialize sutezolid

Catholic Health Initiatives creates new MSO to deliver physician-management services

OneHealth Solutions signs strategic alliance with New Directions Behavioral Health

LodgeNet Healthcare becomes SONIFI HEALTH Solutions

Zecotek partners with Hamamatsu to commercialize existing imaging technologies

ADC Therapeutics, BZL Biologics sign licensing deal for antibody against PSMA-positive prostate cancers

Ipsen closes acquisition of UK-based Syntaxin

PathoQuest closes new fundraising of EUR 3.8 million

Boehringer Ingelheim signs multi-year renewal agreement to NextBio Research Platform

Acorda Therapeutics acquires two neuropathic pain management assets from NeurogesX

Glythera secures £700k to advance development of new generation of biological therapeutics

Leica Biosystems announces acquisition of Kreatech Diagnostics

BioNano Genomics signs strategic partnership with New York Genome Center

Life Care Medical Devices inks exclusive distribution agreement with M.E.D. Surgical

Soligenix announces personalized medicine collaboration with SciClone

Capricor to become wholly-owned subsidiary of Nile Therapeutics

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News